Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a …
T Tada, T Kumada, A Hiraoka, M Hirooka… - European Journal of …, 2022 - journals.lww.com
Objective: To investigate whether neutrophil-to-lymphocyte ratio (NLR) can predict outcomes
in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab …
in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab …
Clinical utility of albumin bilirubin grade as a prognostic marker in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a systematic …
G Mishra, A Majeed, A Dev, GD Eslick… - Journal of …, 2023 - Springer
Purpose Hepatic function is a key prognostic marker in patients with hepatocellular cancer
(HCC) and central to patient selection for transarterial chemoembolization (TACE). We …
(HCC) and central to patient selection for transarterial chemoembolization (TACE). We …
[HTML][HTML] Analyses of intermediate-stage hepatocellular carcinoma patients receiving transarterial chemoembolization prior to designing clinical trials
K Koroki, S Ogasawara, Y Ooka, H Kanzaki… - Liver Cancer, 2020 - karger.com
Background: Intermediate-stage hepatocellular carcinoma (HCC) has a high frequency of
recurrence and progression to advanced stage after transarterial chemoembolization …
recurrence and progression to advanced stage after transarterial chemoembolization …
Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma
L Jianyong, Z Jinjing, Y Lunan, Z Jingqiang… - Scientific reports, 2017 - nature.com
Combinations of transarterial chemoembolization (TACE) and radical therapies
(pretransplantation, resection and radiofrequency ablation) for hepatocellular carcinoma …
(pretransplantation, resection and radiofrequency ablation) for hepatocellular carcinoma …
[HTML][HTML] Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis
S Lin, S Hu, Y Ran, F Wu - Translational Cancer Research, 2021 - ncbi.nlm.nih.gov
Background Neutrophil-to-lymphocyte ratio (NLR) is one predictive factor for poor prognosis
of patients with hepatocellular carcinoma (HCC). In response to contradictory data …
of patients with hepatocellular carcinoma (HCC). In response to contradictory data …
FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE
A Kaewdech, P Sripongpun… - Frontiers in …, 2023 - frontiersin.org
Background Patients with un-resectable hepatocellular carcinoma (HCC) treated with
transarterial chemoembolization (TACE) are a diverse group with varying overall survival …
transarterial chemoembolization (TACE) are a diverse group with varying overall survival …
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
T Terashima, T Yamashita, N Iida… - Hepatology …, 2015 - Wiley Online Library
Aim Inflammation plays a critical role in cancer. The aim of the present study was to
investigate the impact of neutrophil to lymphocyte ratio (NLR) on patients with advanced …
investigate the impact of neutrophil to lymphocyte ratio (NLR) on patients with advanced …
Utility and predictive value of the CRAFITY score in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus tyrosine kinase inhibitors …
L Zhang, T Sun, B Sun, K Zhang, Y Zheng, N Li, L Chen… - BMC cancer, 2024 - Springer
Background The prognostic significance of the CRAFITY score (CR P and AF P in I mmuno T
herap Y) has been demonstrated in hepatocellular carcinoma (HCC) patients receiving …
herap Y) has been demonstrated in hepatocellular carcinoma (HCC) patients receiving …
Prognostic values of inflammation-based scores and fibrosis markers in patients with hepatocellular carcinoma treated with transarterial chemoembolization
Background: Inflammation is a key feature shaping the microenvironment of hepatocellular
carcinoma (HCC), and liver fibrosis is associated with the prognosis of patients with HCC. In …
carcinoma (HCC), and liver fibrosis is associated with the prognosis of patients with HCC. In …
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular …
H Ochi, M Kurosaki, K Joko, T Mashiba… - Hepatology …, 2023 - Wiley Online Library
Aim We investigated pretreatment neutrophil‐to‐lymphocyte ratio (NLR) for predicting
survival outcomes of atezolizumab plus bevacizumab therapy for hepatocellular carcinoma …
survival outcomes of atezolizumab plus bevacizumab therapy for hepatocellular carcinoma …